{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:21:37Z","timestamp":1791037297784,"version":"4.1.0"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2010,7,7]],"date-time":"2010-07-07T00:00:00Z","timestamp":1278460800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0011414","type":"journal-article","created":{"date-parts":[[2010,7,7]],"date-time":"2010-07-07T21:06:59Z","timestamp":1278536819000},"page":"e11414","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":233,"title":["Vitamin C: Intravenous Use by Complementary and Alternative Medicine Practitioners and Adverse Effects"],"prefix":"10.1371","volume":"5","author":[{"given":"Sebastian J.","family":"Padayatty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew Y.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Graham","family":"Espey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne","family":"Drisko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2010,7,7]]},"reference":[{"key":"ref1","article-title":"NBJ's Supplement Business Report 2008: An Analysis of Markets, Trends, Competition and Strategy in the U.S. Dietary Supplement Industry. Figure 3\u201333(Table 1); Figure 4\u201318","year":"2008"},{"key":"ref2","first-page":"209","article-title":"The treatment of poliomyelitis and other virus diseases with vitamin C.","volume":"111","author":"FR Klenner","year":"1949","journal-title":"South Med Surg"},{"key":"ref3","first-page":"101","article-title":"Massive doses of vitamin C and the virus diseases.","volume":"113","author":"FR Klenner","year":"1951","journal-title":"South Med Surg"},{"key":"ref4","first-page":"821","article-title":"Acute hepatitis treated with high doses of vitamin C. Report of a case.","volume":"56","author":"HB Calleja","year":"1960","journal-title":"Ohio Med"},{"key":"ref5","first-page":"61","article-title":"Observations on the dose and administration of ascorbic acid when employed beyond the range of a vitamin in human pathology.","volume":"23","author":"FR Klenner","year":"1971","journal-title":"Journal of Applied Nutrition"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/0306-9877(81)90126-2","article-title":"Vitamin C, titrating to bowel tolerance, anascorbemia, and acute induced scurvy.","volume":"7","author":"RF Cathcart","year":"1891","journal-title":"Med Hypotheses"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0306-9877(95)90137-X","article-title":"Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent.","volume":"44","author":"NH Riordan","year":"1995","journal-title":"Med Hypotheses"},{"key":"ref8","article-title":"Vitamin C the common cold and the flu","author":"L Pauling","year":"1976"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1073\/pnas.73.10.3685","article-title":"Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer.","volume":"73","author":"E Cameron","year":"1976","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1073\/pnas.75.9.4538","article-title":"Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer.","volume":"75","author":"E Cameron","year":"1978","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref11","first-page":"201","article-title":"Clinical and experimental experiences with intravenous vitamin C.","volume":"15","author":"NH Riordan","year":"2000","journal-title":"J Orthomolecular Med"},{"key":"ref12","article-title":"Vitamin C, Infectious Diseases, and Toxins: Curing the Incurable","author":"TE Levy","year":"2002"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/1534735404273861","article-title":"Orthomolecular oncology review: ascorbic acid and cancer 25 years later.","volume":"4","author":"MJ Gonzalez","year":"2005","journal-title":"Integr Cancer Ther"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.freeradbiomed.2009.04.001","article-title":"Losing and finding a way at C: new promise for pharmacologic ascorbate in cancer treatment.","volume":"47","author":"M Levine","year":"2009","journal-title":"Free Radic Biol Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/0003-4819-140-7-200404060-00010","article-title":"Vitamin C pharmacokinetics: implications for oral and intravenous use.","volume":"140","author":"SJ Padayatty","year":"2004","journal-title":"Ann Intern Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1093\/annonc\/mdn377","article-title":"Phase I clinical trial of i.v. ascorbic acid in advanced malignancy.","volume":"19","author":"LJ Hoffer","year":"2008","journal-title":"Ann Oncol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/07315724.2000.10718941","article-title":"Reevaluation of ascorbate in cancer treatment: emerging evidence, open minds and serendipity.","volume":"19","author":"SJ Padayatty","year":"2000","journal-title":"J Am Coll Nutr"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"13604","DOI":"10.1073\/pnas.0506390102","article-title":"Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues.","volume":"102","author":"Q Chen","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"8749","DOI":"10.1073\/pnas.0702854104","article-title":"Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo.","volume":"104","author":"Q Chen","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"11105","DOI":"10.1073\/pnas.0804226105","article-title":"Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice.","volume":"105","author":"Q Chen","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.freeradbiomed.2009.02.016","article-title":"Pharmacologic concentrations of ascorbate are achieved by parenteral administration and exhibit antitumoral effects.","volume":"47","author":"J Verrax","year":"2009","journal-title":"Free Radic Biol Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1001\/archinte.1985.00360050220044","article-title":"Acute oxalate nephropathy after massive ascorbic acid administration.","volume":"145","author":"JM Lawton","year":"1985","journal-title":"Arch Intern Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1445-5994.1994.tb01477.x","article-title":"Acute oxalate nephropathy after a massive intravenous dose of vitamin C.","volume":"24","author":"K Wong","year":"1994","journal-title":"Aust N Z J Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/jama.1984.03350130016019","article-title":"Renal failure secondary to massive infusion of vitamin C.","volume":"252","author":"CJ McAllister","year":"1984","journal-title":"JAMA"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"810","DOI":"10.7326\/0003-4819-82-6-810_1","article-title":"Ascorbic acid-induced hemolysis in G-6-PD deficiency.","volume":"82","author":"GD Campbell Jr","year":"1975","journal-title":"Ann Intern Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/bmj.306.6881.841","article-title":"Acute haemolysis induced by high dose ascorbic acid in glucose-6- phosphate dehydrogenase deficiency.","volume":"306","author":"DC Rees","year":"1993","journal-title":"BMJ"},{"key":"ref27","first-page":"1","article-title":"Complementary and alternative medicine use among adults: United States 2002.","author":"PM Barnes","year":"2004","journal-title":"Adv Data"},{"key":"ref28","first-page":"389","article-title":"Intravenous nutrient therapy: the \u201cMyers' cocktail\u201d.","volume":"7","author":"AR Gaby","year":"2002","journal-title":"Altern Med Rev"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1089\/acm.2008.0410","article-title":"Intravenous micronutrient therapy (Myers' Cocktail) for fibromyalgia: a placebo-controlled pilot study.","volume":"15","author":"A Ali","year":"2009","journal-title":"J Altern Complement Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1001\/jama.281.15.1415","article-title":"Criteria and recommendations for vitamin C intake.","volume":"281","author":"M Levine","year":"1999","journal-title":"JAMA"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1084\/jem.62.4.517","article-title":"Inactivation of poliomyelitis virus in vitro by crystalline vitamin C (ascorbic acid).","volume":"62","author":"CW Jungeblut","year":"1935","journal-title":"Journal of Experimental Medicine"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1084\/jem.66.4.459","article-title":"Further observations on vitamin C therapy in experimental poliomyelitis.","volume":"66","author":"CW Jungeblut","year":"1937","journal-title":"Journal of Experimental Medicine"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1084\/jem.69.4.507","article-title":"Vitamin C in relation to experimental poliomyelitis.","volume":"69","author":"AB Sabin","year":"1939","journal-title":"Journal of Experimental Medicine"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1084\/jem.70.3.315","article-title":"A further contribution to vitamin C therapy in experimental poliomyelitis.","volume":"70","author":"CW Jungeblut","year":"1939","journal-title":"Journal of Experimental Medicine"},{"key":"ref35","first-page":"5","article-title":"Case study: high-dose intravenous vitamin C in the treatment of a patient with adenocarcinoma of the kidney.","volume":"5","author":"HD Riordan","year":"1990","journal-title":"J Orthomolecular Med"},{"key":"ref36","first-page":"313","article-title":"Cancer: the preconditioning factor in pathogenesis; a new etiologic approach.","volume":"71","author":"WJ McCormick","year":"1954","journal-title":"Arch Pediatr"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0140-6736(72)90215-2","article-title":"Ascorbic acid, cell proliferation, and cancer.","volume":"1","author":"E Cameron","year":"1972","journal-title":"Lancet"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1056\/NEJM198501173120301","article-title":"High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison.","volume":"312","author":"CG Moertel","year":"1985","journal-title":"N Engl J Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJM197909273011303","article-title":"Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial.","volume":"301","author":"ET Creagan","year":"1979","journal-title":"N Engl J Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1056\/NEJM198501173120310","article-title":"Vitamin C and cancer.","volume":"312","author":"RE Wittes","year":"1985","journal-title":"N Engl J Med"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1073\/pnas.93.8.3704","article-title":"Vitamin C pharmacokinetics in healthy volunteers: evidence for a Recommended Dietary Allowance.","volume":"93","author":"M Levine","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"9842","DOI":"10.1073\/pnas.171318198","article-title":"A new recommended dietary allowance of vitamin C for healthy young women.","volume":"98","author":"M Levine","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJMc061414","article-title":"Vitamins C and E and the prevention of preeclampsia.","volume":"355","author":"SJ Padayatty","year":"2006","journal-title":"N Engl J Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1053\/j.ajkd.2004.10.025","article-title":"Long-term, low-dose, intravenous vitamin C leads to plasma calcium oxalate supersaturation in hemodialysis patients.","volume":"45","author":"C Canavese","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/0148607104028006435","article-title":"Urinary oxalate excretion increases in home parenteral nutrition patients on a higher intravenous ascorbic acid dose.","volume":"28","author":"V Pena dl","year":"2004","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0140-6736(94)91195-9","article-title":"Haemolysis induced by ascorbic acid in paroxysmal nocturnal haemoglobinuria.","volume":"343","author":"N Iwamoto","year":"1994","journal-title":"Lancet"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/ajh.2830470426","article-title":"Ascorbic acid-induced hemolysis of paroxysmal nocturnal hemoglobinuria erythrocytes.","volume":"47","author":"N Iwamoto","year":"1994","journal-title":"Am J Hematol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"8031","DOI":"10.1158\/0008-5472.CAN-08-1490","article-title":"Vitamin C antagonizes the cytotoxic effects of antineoplastic drugs.","volume":"68","author":"ML Heaney","year":"2008","journal-title":"Cancer Res"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0021-9258(18)56445-0","article-title":"The diabetogenic effect of dehydroascorbic and dehydroisoascorbic acids.","volume":"183","author":"JW Patterson","year":"1950","journal-title":"J Biol Chem"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1152\/ajplegacy.1951.165.1.61","article-title":"Course of diabetes and development of cataracts after injecting dehydroascorbic acid and related substances.","volume":"165","author":"JW Patterson","year":"1951","journal-title":"Am J Physiol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1345\/aph.1E634","article-title":"Life-threatening interaction between complementary medicines: cyanide toxicity following ingestion of amygdalin and vitamin C.","volume":"39","author":"J Bromley","year":"2005","journal-title":"Ann Pharmacother"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0011414","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,31]],"date-time":"2021-10-31T02:01:51Z","timestamp":1635645711000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0011414"}},"subtitle":[],"editor":[{"given":"Joel Joseph","family":"Gagnier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,7,7]]},"references-count":51,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2010,7,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0011414","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,7]]}}}